Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance

scientific article published on 22 September 2016

Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJPHARM.2016.09.063
P698PubMed publication ID27667754

P50authorBrigitte VoitQ21256003
Barbara Klajnert-MaculewiczQ50488876
Łukasz PułaskiQ59188894
Dietmar AppelhansQ59439942
P2093author name stringAleksandra Szulc
P2860cites workDendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applicationsQ38292341
Hyperbranched PEI with various oligosaccharide architectures: synthesis, characterization, ATP complexation, and cellular uptake propertiesQ38355389
Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancerQ39041260
Influence of surface functionality of poly(propylene imine) dendrimers on protease resistance and propagation of the scrapie prion proteinQ43092352
Studying complexes between PPI dendrimers and Mant-ATP.Q43737928
The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: new effects dependent on hydrogen bondingQ46521501
Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.Q50510408
Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.Q53491739
Characteristics of complexes between poly(propylene imine) dendrimers and nucleotidesQ57777281
Internalization and Intracellular Trafficking of Poly(propylene imine) Glycodendrimers with Maltose Shell in Melanoma CellsQ57777323
In vivo toxicity of poly(propyleneimine) dendrimersQ57777440
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectcytarabineQ180983
drug deliveryQ1392806
P304page(s)572-583
P577publication date2016-09-22
P1433published inInternational Journal of PharmaceuticsQ6051539
P1476titleSugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance
P478volume513